The group’s principle activity is to develop technology for the treatment of ocular diseases. The group’s PASCAL(R) method of photocoagulation is used to treat a variety of retinal conditions including diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusive diseases. The group operates from United States.
